Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02203591 · ClinicalTrials.gov registry record · Phase 3
In Vivo Efficacy Study of Patient Preoperative Preps
A Phase 3 study, sponsored by 3M.
- Completed
- Registry status
- Phase 3
- Development phase
- 738
- Enrollment target
NCT02203591 is a Phase 3 study that has completed, run by 3M. The registered enrollment target is 738 participants.
The verdict
NCT02203591, a Phase 3 study, has completed, sponsored by 3M.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 738 participants
- Enrollment target
Study Summary
The objective of this study is to demonstrate the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.
Interventions
- DRUG Normal Saline
- DRUG ChloraPrep
- DRUG 3M CHG/IPA Prep C
- DRUG 3M CHG/IPA Prep CH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 738 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02203591
The ClinicalTrials.gov registry entry for NCT02203591 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 738 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is 3M, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Normal Saline is the first listed.
NCT02203591 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02203591 about?
NCT02203591 is a clinical study titled "In Vivo Efficacy Study of Patient Preoperative Preps". The objective of this study is to demonstrate the antimicrobial efficacy of the 3M CHG/IPA Prep on skin flora of the abdominal and inguinal regions of human subjects.
What is the current status of trial NCT02203591?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 738 participants. The study started on 2014-07. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02203591?
The interventions under investigation include: Normal Saline (DRUG), ChloraPrep (DRUG), 3M CHG/IPA Prep C (DRUG), 3M CHG/IPA Prep CH (DRUG).
Who is sponsoring clinical trial NCT02203591?
This trial is sponsored by 3M, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.